Ahmedabad-based Cadila Pharmaceuticals will invest ₹100 crore to set up a pharmaceuticals formulations manufacturing facility at Malipada near Bhubaneswar in Odisha.
According to the company, it has signed an investment intention... Full Story
Aurobindo Pharma aims to complete Rs. 2000 Cr Pen-G plant in Andhra Pradesh by March'24.
Aurobindo Pharma's aims to complete its Rs. 2,000 crore Penicillin G (Pen G) plant in Andhra Pradesh by March 2024 even as... Full Story
Biological E to invest ₹1,800 crore in Hyderabad to expand vaccine manufacturing capacity.
Biological E will invest over ₹1,800 crore for expanding manufacturing capacity of vaccines along with generic Injectables and Research and Development... Full Story
Ind-Swift expects sales of Rs 1,200 cr Chandigarh: Ind-Swift group, a Chandigarh-based research-driven pharmaceutical group with presence across 45 countries, expects to close the current fiscal with collective sales of Rs 1,200... Full Story